Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Lisa M Meckley"'
Publikováno v:
BMC Immunology, Vol 21, Iss 1, Pp 1-15 (2020)
Abstract Background Often, patients with primary immunodeficiency diseases (PID), which are marked by the absence or loss of functional antibodies, require lifelong treatment with immunoglobulin (IG) replacement therapy administered either intravenou
Externí odkaz:
https://doaj.org/article/4242ba8d6c7243e0a8168c314f1fb0e5
Autor:
Spiros Tzivelekis, Jordan Orange, Christine Poulos, Lisa M Meckley, Holly Peay, Jessie Sutphin, Vivian P Hernandez-Trujillo, Richard L Wasserman
Publikováno v:
Immunotherapy. 15:647-656
Aim: To describe development of a shared decision making (SDM) aid in treating primary immunodeficiency diseases (PID) with immunoglobulin replacement therapy (IGRT). Materials & methods: Expert engagement and qualitative formative research informed
Publikováno v:
BMC Immunology, Vol 21, Iss 1, Pp 1-15 (2020)
BMC immunology, vol 21, iss 1
BMC Immunology
BMC immunology, vol 21, iss 1
BMC Immunology
Background Often, patients with primary immunodeficiency diseases (PID), which are marked by the absence or loss of functional antibodies, require lifelong treatment with immunoglobulin (IG) replacement therapy administered either intravenously (intr
Autor:
Richard F Pollock, Lisa M. Meckley
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Richard F Pollock,1 Lisa M Meckley2 1Ossian Health Economics and Communications GmbH, Health Economics and Outcomes Research, Basel, Switzerland; 2Shire Plc, Outcomes Research and Epidemiology, Cambridge, MA, USA Introduction: While most individual p
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:568-574.e1
Background The safety and efficacy of subcutaneous immune globulin 20% (human) solution (Cuvitru; Ig20Gly) for primary immunodeficiency disease (PID) have been demonstrated in 2 pivotal trials. Objective To describe patient characteristics and infusi
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB216
Autor:
Lisa M. Meckley, G. Miyasato, Sangtaeck Lim, J. Scaife, Mitra Corral, Yajing Rao, Jerome Riebman, Derek Martyn, Richard Kocharian
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Derek Martyn,1 Lisa M Meckley,1 Gavin Miyasato,1 Sangtaeck Lim,2 Jerome B Riebman,3 Richard Kocharian,3 Jillian G Scaife,1 Yajing Rao,1 Mitra Corral2 1Trinity Partners, LLC, Waltham, MA, USA; 2Global Health Economics and Market Access, Ethicon, Inc.,
Autor:
Lisa M. Meckley, Kelly M Shriner, Michael J. Cangelosi, Ayanna M. Anene, Jesse D. Ortendahl, Tanya G. K. Bentley, John Fox
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 15:357-364
We examined the cost-effectiveness of treating poorly controlled, severe, persistent asthma patients with bronchial thermoplasty (BT), a novel technology that uses thermal energy to reduce airway smooth muscle mass, with 5-year outcome data demonstra
Autor:
Lisa M. Meckley, Tanya G K Bentley, Alberto J. Montero, Jose Miguel Martin Martinez, Ayanna M. Anene, Michael J. Cangelosi, Jesse D. Ortendahl
Publikováno v:
Journal of gastrointestinal cancer. 48(1)
ASGE and ESGE guidelines recommend endoscopic metal stent placement for pancreatic carcinoma patients with biliary obstruction, and whose estimated life expectancy is greater than 6 months. Because median overall survival (OS) of metastatic pancreati
Autor:
Lisa M. Meckley
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB118